Collectively, this study provides multi-level evidence from molecular and functional assays to preliminary clinical data, supporting the role of DPP4 inhibition in ameliorating endometrial dysfunction in PCOS. The gene discussed is DPP4; the disease is polycystic ovary syndrome.